Authors:
Carrieri, P
Cailleton, V
Le Moing, V
Spire, B
Dellamonica, P
Bouvet, E
Raffi, F
Journot, V
Moatti, JP
Citation: P. Carrieri et al., The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort, J ACQ IMM D, 28(3), 2001, pp. 232-239
Authors:
Carsenti-Etesse, H
Cavallo, JD
Roger, PM
Ziha-Zarifi, I
Plesiat, P
Garrabe, E
Dellamonica, P
Citation: H. Carsenti-etesse et al., Effect of beta-lactam antibiotics on the in vitro development of resistance in Pseudomonas aeruginosa, CL MICRO IN, 7(3), 2001, pp. 144-151
Authors:
Pradier, C
Carrieri, P
Bentz, L
Spire, B
Dellamonica, P
Moreau, J
Moatti, JP
Citation: C. Pradier et al., Impact of short-term adherence on virological and immunological success ofHAART: a case study among French HIV-infected IDUs, INT J STD A, 12(5), 2001, pp. 324-328
Citation: S. Gindre et al., Anti-pneumococcal vaccination in splenectomized patients - Evaluation of its application from 1995 to 2000 in the University Hospital in Nice, PRESSE MED, 30(32), 2001, pp. 1592-1593
Authors:
Roger, PM
Breittmayer, JP
Cottalorda, J
Ticchioni, M
Mondain, V
Dellamonica, P
Bernard, A
Citation: Pm. Roger et al., Persistent viral load in patients on HAART is associated with a higher level of activation-induced apoptosis of CD4(+) T cells, J ANTIMICRO, 47(1), 2001, pp. 109-112
Authors:
Chaix, C
Grenier-Sennelier, C
Clevenbergh, P
Durant, J
Schapiro, JM
Dellamonica, P
Durand-Zaleski, I
Citation: C. Chaix et al., Economic evaluation of drug resistance genotyping for the adaptation of treatment in HIV-infected patients in the VIRADAPT study, J ACQ IMM D, 24(3), 2000, pp. 227-231
Authors:
Clevenbergh, P
Durant, J
Halfon, P
del Giudice, P
Mondain, V
Montagne, N
Schapiro, JM
Boucher, CAB
Dellamonica, P
Citation: P. Clevenbergh et al., Persisting long-term benefit of genotype-guided treatment for HIV-infectedpatients failing HAART. The Viradapt study: week 48 follow-up, ANTIVIR TH, 5(1), 2000, pp. 65-70
Authors:
Roger, PM
Hyvernat, H
Verleine-Pugliese, S
Bourroul, C
Giordano, J
Fosse, T
Mousnier, A
Dellamonica, P
Mattei, M
Bernardin, G
Citation: Pm. Roger et al., Short-term impact of systematic infectiology consultation on antibiotic use in an intensive care unit, PRESSE MED, 29(30), 2000, pp. 1640-1644
Authors:
Vandenbos, F
Roger, PM
Mondain-Milton, V
Burel, F
Hofman, V
Dellamonica, P
Citation: F. Vandenbos et al., Cerebral aspergillosis and neuro-meningeal cryptococcosis in a patient with AIDS., MED MAL INF, 30(7), 2000, pp. 474-476
Authors:
Carrieri, MP
Vlahov, D
Dellamonica, P
Gallais, H
Lepeu, G
Spire, B
Obadia, Y
Citation: Mp. Carrieri et al., Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART, DRUG AL DEP, 60(1), 2000, pp. 51-54
Authors:
Durant, J
Clevenbergh, P
Garraffo, R
Halfon, P
Icard, S
Del Giudice, P
Montagne, N
Schapiro, JM
Dellamonica, P
Citation: J. Durant et al., Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the ViradaptStudy, AIDS, 14(10), 2000, pp. 1333-1339
Authors:
Roger, PM
Vandenbos, F
Mondain-Miton, V
Ticchioni, M
Dellamonica, P
Citation: Pm. Roger et al., Mycobacterium avium-positive pulmonary sample and CD4(+) lymphopenia not related to human HIV, REV MED IN, 21(1), 2000, pp. 116-117